Calling all Model-Informed Drug Developers, you are invited!
Join DILIsym Services Chief Scientific Officer, Scott Q Siler, who will describe the features and use of IPFsym v1A to support the development of effective treatments for IPF patients.
Extends reach of MonolixSuite™ to China’s growing pharmacology market
Join us on International Day for Women and Girls in Science for webinar presented by Jill Fiedler-Kelly, President of Cognigen
This update will include NEW inhibition and induction mechanisms of perpetration for both enzymes and transporters.
To improve the productivity of science-based research & development enterprises by delivering innovative modeling and simulation software and insightful consulting services.
Providing strategic pharmacology and pharmacometric consulting services, PK/PD model development with NONMEM, clinical trial simulations, exposure-response evaluations, dose justification strategies and related data management services.
Ensuring the safety of drug therapies by leveraging our expertise in the areas of drug-induced liver injury, metabolic diseases, and modeling and simulation.
Lixoft products are designed to save the time and energy of pharmacometricians and biostatisticianby bringing breakthrough advances to the modeling & simulation community in user-friendly tools.
Stay up-to-date with our upcoming conference attendance & presentations, application webinars, and training workshop courses.
Find out how your peers are applying our technology by reviewing journal articles describing various user case studies.